Using a reporter gene system, preliminary clinical evidence supports trafficking of intracerebrally administered anti-IL13Rα2 CAR T cells to the tumor region using [18F]FHBG PET-based imaging [89]. The gene discussed is IL13RA2; the disease is neoplasm.